Restech articles

If your doctor says a certain drug or therapy would be beneficial in treating you, your insurance company still needs to agree to pay for it.  This can be frustrating for patients and practitioners when they are trying to improve a chronic condition such as GERD or LPR.  

In order for an insurance company to change their coverage policies, they need to be presented with certain information to convince them that the procedure is safe, reliable, and effective, both medica

Hvid-Jensen F, Pedersen L, Funch-Jensen P, Drewes A. Aliment Pharmacol Ther. 2014 May;39(9):984-91.

OBJECTIVES: To investigate if the intensity and adherence of PPI use among all patients with BO in Denmark affected the risk of oesophageal adenocarcinoma.

RESULTS: We identified 140 cases with incident o

We’ve all been there. In our doctor’s office, or on the phone with their billing manager, being told that a drug or procedure we hoped for is not covered by our insurance plan. After weeks or even months of researching online, talking to other patients, and comparing alternatives, we’ve been told that our insurance plan simply will not cover that solution. Our frustration is shared by the doctor, who has had success with that procedure or drug on patients just like us. 

A recent study investigating the relationship between LPR and Allergic Rhinitis (AR) found a significant correlation, where there used to be doubt.

In this prospective, case-control study published in the International Archives of Allergy and Immunology, Chang et al. found that both the incidence and severity of AR are higher in patients who have an objective diagnosis of LPR obtained by Restech’s Dx-pH System.

A total of 102 pa